CHARLES HICKS, Associate Professor Medicine, Duke University, Durham REFERENCE: Lancet 2006; 368: 466-75 Results with a new antiretroviral agent, tipranavir, tested among patients who were resistant t
CHARLES HICKS, Associate Professor Medicine, Duke University, Durham
REFERENCE: Lancet 2006; 368: 466-75
Results with a new antiretroviral agent, tipranavir, tested among patients who were resistant to standard therapies have been published in The Lancet.Charles Hicksof Duke University in North Carolina told Sarah Maxwell about the treatment responses they’ve reported and the potential role of this agent for treating late stages of HIV infection.
Related Episodes
Tropical Health Research: London Scientist Honored
Brian Greenwood Brian Greenwood, London School of Hygiene and Tropical Medicine Brian Greenwood has won the Hideyo Noguchi Africa Prize for his numerous achievements in tropical disease research. He t
Audio Journal of Oncology in Advance – March 15th, 2008
Volume 16 Number 6 (March 15th, 2008) reporting from: 4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris) American Society of Hematology Annual Meeting (December 8-11, 2007
“Total Therapy” Possible Cure For Multiple Myeloma?
Bart Barlogie Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 BART BARLOGIE, University of Arkansas, Little Rock A treatment known as “total therapy